UnitedHealth Group Incorporated (NYSE:UNH - Free Report) - Research analysts at Cantor Fitzgerald lifted their FY2024 earnings estimates for shares of UnitedHealth Group in a research report issued on Monday, December 9th. Cantor Fitzgerald analyst S. James now anticipates that the healthcare conglomerate will post earnings of $27.60 per share for the year, up from their previous estimate of $27.56. Cantor Fitzgerald currently has a "Overweight" rating and a $644.00 target price on the stock. The consensus estimate for UnitedHealth Group's current full-year earnings is $27.63 per share.
Several other brokerages also recently issued reports on UNH. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a report on Wednesday, October 16th. UBS Group dropped their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a research note on Wednesday, October 16th. Oppenheimer increased their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a report on Friday. Bank of America decreased their price target on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a research note on Wednesday, October 16th. Finally, KeyCorp assumed coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an "overweight" rating and a $675.00 price objective for the company. Three research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $626.84.
Get Our Latest Research Report on UNH
Shares of NYSE UNH opened at $561.10 on Tuesday. The company has a market cap of $516.37 billion, a price-to-earnings ratio of 36.55, a price-to-earnings-growth ratio of 1.61 and a beta of 0.58. The stock's 50 day simple moving average is $586.36 and its 200 day simple moving average is $559.39. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a 12-month low of $436.38 and a 12-month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company's revenue for the quarter was up 9.2% on a year-over-year basis. During the same period last year, the firm posted $6.56 EPS.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.50%. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.72%.
Institutional investors and hedge funds have recently modified their holdings of the business. International Assets Investment Management LLC lifted its position in UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock worth $3,096,896,000 after buying an additional 5,290,025 shares in the last quarter. Lone Pine Capital LLC purchased a new stake in shares of UnitedHealth Group during the second quarter worth $480,903,000. Dimensional Fund Advisors LP grew its stake in UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate's stock valued at $1,942,956,000 after purchasing an additional 880,183 shares in the last quarter. Baillie Gifford & Co. lifted its holdings in shares of UnitedHealth Group by 1,125.4% during the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate's stock valued at $455,281,000 after buying an additional 821,050 shares during the last quarter. Finally, Accredited Investors Inc. increased its holdings in UnitedHealth Group by 9,235.4% in the third quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate's stock worth $458,929,000 after buying an additional 776,516 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.